C. B. Hare

发表

Redefining user input on handheld devices

C. B. Hare, 2002 .

Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation

C. B. Hare, J. Volk, L. Hurley, 2016, Journal of acquired immune deficiency syndromes.

The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

C. B. Hare, K. Tashima, S. Little, 2012, The Journal of infectious diseases.

Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.

C. B. Hare, D. Havlir, J. Mellors, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents

C. B. Hare, S. Keir, D. Bigner, 1998, Cancer Chemotherapy and Pharmacology.

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts

C. B. Hare, S. Keir, D. Bigner, 1996, Cancer Chemotherapy and Pharmacology.

Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

C. B. Hare, D. Havlir, P. Tien, 2006, Journal of acquired immune deficiency syndromes.

Clinical experience with nonstandard doses ofinterferon alfa-2b and ribavirin in the treatment of chronic hepatitis C infection: A retrospective analysis.

C. B. Hare, W. Klaskala, V. Gotz, 2005, Current therapeutic research, clinical and experimental.

Comparison of characteristics of treated and non‐treated patients with Hepatitis C infection

C. B. Hare, W. Klaskala, V. Gotz, 2006, Pharmacoepidemiology and drug safety.

Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV

C. B. Hare, J. Volk, D. Satre, 2019, Sexually Transmitted Infections.

Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft

C. B. Hare, S. Keir, D. Bigner, 1997, Cancer Chemotherapy and Pharmacology.

Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care

C. B. Hare, Vanessa A. Palzes, J. Flamm, 2022, AIDS and Behavior.

Health System-Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically-Matched Participants With and Without HIV.

C. B. Hare, J. Sterne, A. Justice, 2020, Alcoholism, clinical and experimental research.

Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.

C. B. Hare, D. Havlir, M. Pandori, 2011, Journal of Virological Methods.

Age group differences in substance use, social support, and physical and mental health concerns among people living with HIV two years after receiving primary care-based alcohol treatment

C. B. Hare, J. Lam, D. Satre, 2022, Aging & mental health.

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens

C. B. Hare, Kristin L. Sainani, R. Shafer, 2020, Open forum infectious diseases.

Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.

C. B. Hare, H. Lampiris, C. Grunfeld, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mortality Among Antiretroviral-Eligible Patients in an Urban Public Clinic

C. B. Hare, D. Havlir, D. Dowdy, 2011, Journal of acquired immune deficiency syndromes.

Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings

C. B. Hare, J. Volk, Al Liu, 2016, Current HIV/AIDS Reports.

Resistance Patterns and Response to Entecavir Intensification Among HIV-HBV–Coinfected Adults With Persistent HBV Viremia

C. B. Hare, D. Havlir, E. Charlebois, 2011, Journal of acquired immune deficiency syndromes.

No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

C. B. Hare, J. Volk, D. Nguyen, 2015, Clinical Infectious Diseases.

Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

C. B. Hare, J. Volk, J. Marcus, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Rates of Hepatitis Screening and Vaccination of HIV-Infected MSM in HIV Clinics

C. B. Hare, C. Kent, K. Workowski, 2012, Sexually transmitted diseases.

Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

C. B. Hare, H. Günthard, D. Havlir, 2010, The Journal of infectious diseases.

The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.

C. B. Hare, J. Kahn, D. Havlir, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Partnership 2-1-2013 Leveraging a Rapid , Round-the-Clock HIV Testing System to Screen for Acute HIV Infection in a Large Urban Public Medical Center

C. B. Hare, M. Pandori, J. Klausner, 2016 .

Primary HIV infection

C. B. Hare, J. Kahn, C. Hare, 2004, Current infectious disease reports.

The Essentials of HIV: A Review for Nurses

C. B. Hare, S. Pinkerton, A. Petroll, 2008, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Sexually Transmitted Infection Screening in Key Populations of Persons Living with HIV

C. B. Hare, J. Lam, D. Satre, 2022, AIDS and Behavior.

A Pharmacist‐Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV‐Positive Patients

C. B. Hare, M. Gandhi, Edgar Pierluissi, 2017, Pharmacotherapy.

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

C. B. Hare, H. Günthard, D. Havlir, 2010, AIDS.